Correlation Between Cannara Biotech and CTT Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and CTT Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and CTT Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and CTT Pharmaceutical Holdings, you can compare the effects of market volatilities on Cannara Biotech and CTT Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of CTT Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and CTT Pharmaceutical.

Diversification Opportunities for Cannara Biotech and CTT Pharmaceutical

0.0

Correlation Coefficient

Cannara Biotech  CTT Pharmaceutical

Pay attention - limited upside

The 3 months correlation between Cannara and CTT is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and CTT Pharmaceutical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CTT Pharmaceutical and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with CTT Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CTT Pharmaceutical has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and CTT Pharmaceutical go up and down completely randomly.

Pair Corralation between Cannara Biotech and CTT Pharmaceutical

Assuming the 90 days horizon Cannara Biotech is expected to generate 51.52 times less return on investment than CTT Pharmaceutical. But when comparing it to its historical volatility, Cannara Biotech is 5.32 times less risky than CTT Pharmaceutical. It trades about 0.01 of its potential returns per unit of risk. CTT Pharmaceutical Holdings is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  2.79  in CTT Pharmaceutical Holdings on September 14, 2024 and sell it today you would earn a total of  0.91  from holding CTT Pharmaceutical Holdings or generate 32.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Cannara Biotech  vs.  CTT Pharmaceutical Holdings

Cannara Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

CTT Pharmaceutical

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CTT Pharmaceutical Holdings are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, CTT Pharmaceutical demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cannara Biotech and CTT Pharmaceutical

The main advantage of trading using opposite Cannara Biotech and CTT Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, CTT Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTT Pharmaceutical will offset losses from the drop in CTT Pharmaceutical's long position.

The idea behind Cannara Biotech and CTT Pharmaceutical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.